Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05827016 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05827016 · ClinicalTrials.gov record · last posted 2026-07-02

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Name: A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma — clinical trial record (NCT05827016)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhasePhase 3

SponsorBristol-Myers Squibb

Started2023-06-22

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).

Protocol amendment history 2 changes detected by DataLookout

2026-07-03

Trial status changed: Recruiting → Active, Not Recruiting

2026-07-03

Trial sites reduced: 285 → 271 locations

Trial Details

NCT Number	NCT05827016
Lead Sponsor	Bristol-Myers Squibb
Conditions	Multiple Myeloma
Enrollment	1,230 participants
Start Date	2023-06-22
Primary Completion	2029-03-15 (estimated)
Study Completion	2036-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-02